CClinicalTrials.gg
Status unknownNCT04527692MOSAIKUpdated Aug 26, 2020

Quality of Life of Children/Adolescents in Palliative Care Settings

An observational study in Palliative Care, sponsored by University Hospital, Toulouse. Status unknown at 1 site in France. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2020-08-26.

Sponsored by University Hospital, Toulouse · Observational

The sponsor has not verified this record recently (last verified Aug 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
320
Ages
1 Year to 18 Years
Sex
All
01

Study summary

Investigators will propose to each family monitored by the teams to participate in the study (children between 1 and 18 years old, families understanding and speaking a minimum of French).

Semi-directed interviews are organized with children/adolescents and their parents who have agreed to participate in the study. The interviews are conducted by the care teams themselves. Socio-demographic data are collected.

Read the detailed description

An information letter will be distributed to the children and parents and their non opposition to their participation will be sought (or assent for the child via a written document adapted to the age) will be systematically requested.

Several instruments will be used by the members of the paediatric teams during their routine home or hospital visits to children and their families: the CPOS (Downing 2018), the KINDL (generic questionnaire on quality of life validated for healthy children, Erhart et al. 2009), the QOLLTI-F v.2 (questionnaire on quality of life for parents, Cohen 2007, 2015).

The interviews will therefore be semi-directed interviews with children/adolescents and their parents who have agreed to participate in the study. The interviews will be conducted by the care teams themselves. In addition to the CPOS, KINDL and QOOLTI-F, socio-demographic data are collected.

02

Conditions studied

  • Palliative Care

Keywords

  • child
  • parents
  • quality of life
03

In context

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 794 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Child/parent pair agrees to participate, they give their agreement orally and their non-opposition is documented in the patient's medical record.

Interviews are conducted at home and/or at the hospital depending on where the child is usually cared for by the usual care team.

Inclusion criteria

  • Children/adolescents aged 1 to 18 years with a serious illness and requiring follow-up by a regional pediatric palliative care resource team and/or temporarily hospitalized.
  • Having given his non-opposition to his participation.
  • A minor of whom at least one of the two holders of parental authority has given his or her consent to the participation of their child.
  • Child of whom one of the two holders of parental authority has himself agreed to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Children/adolescents at the end of life (imminent death foreseeable).
  • Children/adolescents and their parents who do not understand French.
  • Child or parent under legal protection (guardianship, curatorship).
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
320 participants (estimated)
Patient registry
No

Groups and cohorts

  • Child

    Children/adolescents from 1 to 18 years of age with a serious illness requiring follow-up by a regional pediatric palliative care resource team and/or temporarily hospitalized.

    Other: Questionnaire

  • Parents

    Adult person with parental authority over a child between the ages of 1 and 18 who is a carrier of a serious illness and requires follow-up by a regional pediatric palliative care resource team and/or is temporarily hospitalized.

    Other: Questionnaire

Interventions

  • OtherQuestionnaire

    semi-structured interviews on the quality of life

06

What researchers measure

Primary outcomes

  1. Quality of life measure

    Exploring the quality of life of children/adolescents in palliative settings and that of their parents through the development of the Childrens palliative outcome scale.

    Time frame: Day 1

Secondary outcomes

  1. psychometric measure - KINDL

    using the validated questionnaire KINDL, French version

    Time frame: Day 1

  2. psychometric measure - QOLLTI-F

    using the the validated questionnaire Quality of life in life threatening illness-family caregiver QOLLTI-F.

    Time frame: Day 1

  3. psychometric measure - Children's palliative outcome scale

    Documentation of the psychometric properties of the Children's palliative outcome scale

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Agnès SUC
    Toulouse, 31059, France
    • Agnes SUC, MD · Contact · suc.a@chu-toulouse.fr · 05 34 55 86 61
    • Agnès SUC, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04527692
Lead sponsor
University Hospital, Toulouse
Responsible party
Sponsor
First posted
Aug 26, 2020
Start date
Apr 15, 2020
Primary completion
Dec 15, 2020 (estimated)
Completion
Nov 15, 2022 (estimated)
Last update
Aug 26, 2020

Study contacts

Agnes SUC, MD
Contact
suc.a@chu-toulouse.fr
5 34 55 86 61 ext. +33
Agnes SUC, MD
principal investigator · Toulouse University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion